Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1275 of 2400 entries
View as:

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000756 Org: User:
Start: - End: 06/30/02 Due: 06/30/03

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00000940 Org: User:
Start: 05/31/99 End: 10/31/06 Due: 10/31/07

A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000662 Org: User:
Start: - End: 05/31/93 Due: 05/31/94

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT00000952 Org: User:
Start: - End: 01/31/04 Due: 01/31/05

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Phase: N/A Priority: Normal
NCT ID: NCT00000641 Org: User:
Start: - End: 12/31/94 Due: 12/31/95

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

Phase: N/A Priority: Normal
NCT ID: NCT00000657 Org: User:
Start: - End: 09/30/92 Due: 09/30/93

Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples

Phase: N/A Priority: Normal
NCT ID: NCT00000928 Org: User:
Start: - End: 07/31/99 Due: 07/31/00

Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00000740 Org: User:
Start: - End: 09/30/93 Due: 09/30/94

Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis

Phase: N/A Priority: Normal
NCT ID: NCT00000894 Org: User:
Start: - End: - Due: -

A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants

Phase: N/A Priority: Normal
NCT ID: NCT00000829 Org: User:
Start: - End: 10/31/99 Due: 10/31/00

A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00000905 Org: User:
Start: - End: - Due: -

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000912 Org: User:
Start: - End: 05/31/00 Due: 05/31/01

HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00000799 Org: User:
Start: - End: 04/30/96 Due: 04/30/97

The Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related Complex

Phase: N/A Priority: Normal
NCT ID: NCT00000986 Org: User:
Start: - End: 01/31/94 Due: 01/31/95

A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

Phase: N/A Priority: Normal
NCT ID: NCT00000970 Org: User:
Start: - End: 06/30/93 Due: 06/30/94

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

Phase: N/A Priority: Normal
NCT ID: NCT00000758 Org: User:
Start: - End: 04/30/98 Due: 04/30/99

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

Phase: N/A Priority: Normal
NCT ID: NCT00000844 Org: User:
Start: - End: 06/30/02 Due: 06/30/03

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

Phase: N/A Priority: Normal
NCT ID: NCT00000794 Org: User:
Start: - End: 04/30/98 Due: 04/30/99

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000669 Org: User:
Start: - End: - Due: -

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)

Phase: N/A Priority: Normal
NCT ID: NCT00000968 Org: User:
Start: - End: 08/31/93 Due: 08/31/94

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00000835 Org: User:
Start: - End: - Due: -

A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000881 Org: User:
Start: - End: - Due: -

A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000945 Org: User:
Start: - End: 03/31/01 Due: 03/31/02

A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00000827 Org: User:
Start: - End: 04/30/98 Due: 04/30/99

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00000658 Org: User:
Start: - End: 02/29/96 Due: 02/28/97